Renaissance Capital logo

Envoy Medical (Anzu Special Acquisition I) Priced, Nasdaq: COCH

Blank check company targeting transformative technologies for industrial applications (completed 10/2/2023).

Industry: SPAC

First Day Return: 0.0%

Industry: SPAC

We are a newly incorporated blank check company. We plan to utilize the financial, operational, public market and investment evaluation experience of our management, members of our board of directors and the advisory board and members of management of Anzu Partners, an entity of which our Chief Executive Officer is a Co-Founder and Managing Partner, to identify and complete our initial business combination with a company that we believe has compelling potential for value creation. Over the course of their careers, the members of our management team, board and advisory board and their affiliates (including Anzu Partners) have developed a broad network of contacts and corporate relationships, including deep networks in industrial technology and global management consulting, that we believe will serve as a useful source of opportunities. While we may pursue an initial business combination target in any industry, we currently intend to concentrate our efforts in identifying high-quality businesses with transformative technologies for industrial applications. Within this focus, we will seek to pursue opportunities with market-leading companies, including from corporate spin-outs, closely-held companies, and institutionally-backed businesses.
more less

Envoy Medical (Anzu Special Acquisition I) (COCH) Performance